Specific treatment
PreclinicalSmall molecule
Specific treatment is one of 8 small molecule programs targeting Corneal Ulcer. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Endometrial
#DrugCompanyPhaseTrials
1Cataflam
NovartisPreclinical
Orgalutran
OOrganon and Co
Preclinical
Specific treatment
AAssistance Publique - Hôpitaux de Paris
Preclinical
Human Chorionic Gonadotrophin
TThe Egyptian IVF-ET Center
Preclinical
Methoxyflurane - Penthrox
UUniversity of Manitoba
Preclinical
Human Menopausal Gonadotrophin
RReproductive & Genetic Hospital of CITIC-Xiangya
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Specific treatment. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details